In the wake of cannabis legalization, a team of scientists at the Research Institute of the McGill University Health Centre (MUHC) and McGill University have delivered encouraging news for chronic pain sufferers by pinpointing the effective dose of marijuana plant extract cannabidiol (CBD) for safe pain relief without the typical “high” or euphoria produced by the THC. The findings of their study have been published in the journal PAIN.

 

Classified as: faculty of medicine, Research Institute of the McGill University Health Centre, RI-MUHC, cannabis, CBD, health and lifestyle
Category:
Published on: 25 Oct 2018
Back to top